Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

VERSANT Begins Trading on Nasdaq Today as Independent Company Following Completion of Comcast Spin-Off

NEW YORK--(BUSINESS WIRE)--VERSANT (Nasdaq: VSNT) today announced the completion of its spin-off from Comcast (Nasdaq: CMCSA). VERSANT will commence trading today on the Nasdaq Stock Market under the ticker symbol VSNT. VERSANT is an industry-changing media and entertainment business that operates in four core markets: political news and opinion, business news and personal finance, golf and athletics participation and sports and genre entertainment. The company serves these markets primarily th...
-

Crane Company Completes Acquisition of Precision Sensors & Instrumentation and Announces Date for Fourth Quarter 2025 Earnings Release and Teleconference

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE:CR) (“Crane” or the “Company”), a premier industrial manufacturing and technology company, today announced that it has closed on the previously announced acquisition of Precision Sensors & Instrumentation (“PSI”), a leading provider of sensor-based technologies for aerospace, nuclear and process industries, from Baker Hughes (NASDAQ: BKR). Crane will provide comments about the acquisition in its upcoming fourth quarter fiscal year 2025 e...
-

Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, at 3:00 p.m. PST / 6:00 p.m. EST. A live webcast of the presentation will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations, and an archived replay will be available for up to 3...
-

Rayonier Advanced Materials Announces the Appointment of Scott M. Sutton as Chief Executive Officer

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (“RYAM” or the “Company”) today announced that its Board of Directors has appointed Scott M. Sutton as Chief Executive Officer, and President, effective January 5, 2026. Mr. Sutton will also join the Company’s Board of Directors. Mr. Sutton, former President and Chief Executive Officer of Olin Corporation, brings more than three decades of global leadership experience in the chemicals and materials sectors, including a proven...
-

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq

BOSTON & TORONTO--(BUSINESS WIRE)--Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs, today announced that the Company will operate under the business name Helus Pharma (pronounced “Heal-Us”) and trade on Nasdaq with ticker symbol HELP. “Our new business name more accurately describes our compounds and reflects our anticipated transformation from a...
-

agilon health, inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AGL

LOS ANGELES--(BUSINESS WIRE)--agilon health, inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AGL...
-

Arrowhead Pharmaceuticals annonce l’approbation de REDEMPLOMC (plozasiran) par Santé Canada pour réduire les triglycérides chez les adultes atteints du syndrome de chylomicronémie familiale (SCF)

PASADENA, Californie--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ : ARWR) a annoncé aujourd’hui que Santé Canada a émis un avis de conformité (AC) autorisant REDEMPLOMC (plozasiran), un médicament à base de petit acide ribonucléique interférent (pARNi), en complément d’une alimentation appropriée, pour la réduction des triglycérides chez les adultes atteints du syndrome de chylomicronémie familiale (SCF) chez qui les traitements classiques de réduction des triglycérides sont ineffi...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Element Solutions Inc Completes Acquisition of EFC Gases & Advanced Materials

MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE:ESI) (the “Company” or “ESI”), a global and diversified specialty chemical technology company, announced today that it has completed its previously announced acquisition of EFC Gases & Advanced Materials (“EFC”). EFC will operate as a standalone business unit reported within the Company’s newly renamed “Specialties Segment” which was heretofore the “Industrial & Specialty Segment.” Chief Executive Officer Benjamin Gliklich said, “We ar...